← FDA Drug Approvals (Drugs@FDA)
EFAVIRENZ
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAR FORMULATIONS PRIVATE LTD · Approved 2012-06-25
Drug application
- FDA Application #
ANDA202990- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EFAVIRENZ
- Generic name
- Efavirenz
- Active ingredients
- EFAVIRENZ
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- PAR FORMULATIONS PRIVATE LTD
- First approval
- 2012-06-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown